共 50 条
- [1] COMPARISON OF EFFICACY AND TOLERABILITY OF TWO SELECTIVE M3 RECEPTOR ANTAGONISTS SOLIFENACIN AND DARIFENACIN IN WOMEN WITH OVERACTIVE BLADDER - THE SOLIDAR STUDYINTERNATIONAL UROGYNECOLOGY JOURNAL, 2010, 21 : S413 - S415But, IPakiz, M.Hlebic, G.Poteko, S.Rozic, N.Venier, B.
- [2] Comparison of Two Selective Muscarinic Receptor Antagonists (Solifenacin and Darifenacin) in Women with Overactive Bladder - the SOLIDAR StudyCOLLEGIUM ANTROPOLOGICUM, 2012, 36 (04) : 1347 - 1353But, IgorGoldstajn, Marina SpremOreskovic, Slavko
- [3] Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladderWorld Journal of Urology, 2005, 23 : 248 - 252Norman ZinnerJohn TuttleLeonard Marks
- [6] Darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA) for overactive bladder, does not prolong QT/QTcBRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 633 - 633Serra, DBAffrime, MBBedigian, MPGreig, GWang, YDanahay, H
- [7] A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladderBJU INTERNATIONAL, 2005, 95 (07) : 993 - 1001Chapple, CSteers, WNorton, PMillard, RKralidis, GGlavind, KAbrams, P
- [9] Darifenacin, an M3 selective receptor antagonist, reduces the frequency of nocturnal awakening, an important symptom of overactive bladderJOURNAL OF UROLOGY, 2004, 171 (04): : 131 - 131Khullar, V